IRUS Total

The Biological Role of Factor-Inhibiting Hypoxia- Inducible Factor

File Description SizeFormat 
Khan-MN-2009-PhD-Thesis.pdf8.01 MBAdobe PDFView/Open
Title: The Biological Role of Factor-Inhibiting Hypoxia- Inducible Factor
Authors: Khan, Moddasar N.
Item Type: Thesis or dissertation
Abstract: Factor Inhibiting Hypoxia-inducible Factor (FIH) is an asparaginyl hydroxylase which regulates the transcription factor Hypoxia-Inducible Factor (HIF), via hydroxylation of a conserved asparagine residue of the HIF-alpha subunits (two isoforms of which are well established, HIF-1 and HIF-2alpha – HIF-3alpha is less well characterized currently). Other targets of FIH have also been reported. Little is known about both FIH expression and function. This thesis will investigate the expression of FIH in rodents, in cell lines and in renal cancer tissue samples. In addition, RNAi technology was used to study FIH function. Clear cell renal cell carcinoma (CCRCC) is commonly associated with inactivation of tumour suppressor von-Hippel Lindau protein (VHL) and constitutive activation of HIF. The main question I have addressed in this thesis is whether FIH decreases HIF activation in this setting. To address this I inhibited FIH using several approaches. Specifically, using hypoxia, dimethyloxalylglycine (DMOG) and RNA interference (RNAi). Each of these increased the expression of HIF target genes in two different CCRCC cell lines, RCC10 and RCC4. Investigating three different CCRCC cell lines, FIH inhibition decreased numbers of RCC4 and RCC10 cells growing in culture, which is likely to be due to an increase in expression of pro-apoptotic, FIH-regulated HIF target genes. Interestingly, 786-O cells exclusively express the HIF-2alpha isoform. Attenuation of FIH in this setting did not affect expression of HIF target genes, nor affect growth in culture. To determine if this was due to lack of FIH or may be due to lack of HIF-1alpha, I introduced HIF-1alpha via a viral vector. Following this, sensitivity to FIH was clearly demonstrated. This implies either specific ‘protection’ of HIF-2alpha in 786-O or more general FIH selectivity for the HIF- 1alpha isoform. My findings contrast with two reports suggesting that FIH expression is suppressed in CCRCC. My findings give insight into how FIH asparagine hydroxylation regulates HIF, in particular in renal cancer and makes this enzyme a potential target for therapeutic inhibition, in the majority of renal cancers.
Issue Date: 2008
Date Awarded: Feb-2009
URI: http://hdl.handle.net/10044/1/4645
DOI: https://doi.org/10.25560/4645
Supervisor: Maxwell, Patrick
Kiriakidis, Serafim
Author: Khan, Moddasar N.
Department: Renal
Publisher: Imperial College London
Qualification Level: Doctoral
Qualification Name: Doctor of Philosophy (PhD)
Appears in Collections:Department of Metabolism, Digestion and Reproduction

Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons